Influence of 18F-PDG-PET on treatment in patients with differentiated thyroid cancer.

被引：0
作者：
Schlyter, B [1 ]
Plotkin, M [1 ]
Klutmann, S [1 ]
Beyer, W [1 ]
Bohuslavizki, H [1 ]
Mester, J [1 ]
Clausen, M [1 ]
机构：
[1] Univ Hamburg, Hosp Eppendorf, D-20246 Hamburg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1041
引用
收藏
页码：234P / 234P
页数：1
相关论文
共 50 条
[41]   18F-Fluorodeoxyglucose Uptake in Metastases of Differentiated Thyroid Cancer: Does It Influence The Prognosis ? [J].
Menzel, C. ;
Zaplatnikov, K. ;
Doebert, N. ;
Diehl, M. ;
Hamscho, N. ;
Kovacs, A. ;
Gruenwald, F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 :S28-S29
[42]   Utility of 18F-FDG-PET (PET) in the diagnosis of local recurrence or metastasis in follow-up of patients treated for Differentiated Thyroid Cancer [J].
Esteva-Fernandez, D. ;
Muros, M. A. ;
Bellon-Guardia, M. ;
Cabello-Garcia, D. ;
Macias-Mir, P. ;
Lopez-Ruiz, J. M. ;
Jimenez-Alonso, J. ;
Llamas-Elvira, J. M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 :S101-S101
[43]   Safety of denosumab in patients with refractory differentiated thyroid cancer and advanced medullary thyroid cancer. [J].
Wassermann, Johanna ;
Mathy, Elise ;
Lescaille, Geraldine ;
Slim, Marine ;
Buffet, Camille ;
Saie, Clotilde ;
Braik-Djellas, Yasmin ;
Simon, Jean-Marc ;
Menegaux, Fabrice ;
Tresallet, Christophe ;
Chami, Linda ;
Lussey-Lepoutre, Charlotte ;
Herve, Genevieve ;
Bernier, Marie-Odile ;
Spano, Jean-Philippe ;
Leenhardt, Laurence .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[44]   Clinical and pathological factors related to 18F-FDG-PET (PET) positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer (DTC) [J].
Muros, M. A. ;
Esteva-Fernandez, D. ;
Gallego, M. ;
Santiago-Chinchilla, A. ;
Muros, T. ;
Torres-Vela, E. ;
Lopez-Ruiz, J. M. ;
Ramirez, A. ;
Llamas-Elvira, J. M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 :S374-S374
[45]   The predicting value of 18F-FDG PET/CT imaging of radioactive iodine treatment efficacy in patients with bone metastasis from differentiated thyroid cancer [J].
Wang, D. ;
Ma, C. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S885-S885
[46]   Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT, and bone scintigraphy in detection of bone metastases of differentiated thyroid cancer [J].
Ota, N. ;
Kato, K. ;
Iwano, S. ;
Ito, S. ;
Tsuchiya, K. ;
Okochi, Y. ;
Okada, Y. ;
Naganawa, S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 :S383-S383
[47]   Influence of F-18FDG PET-CT fusion on radiotherapy treatment planning for head and neck cancer. [J].
Koshy, M ;
Paulino, AC ;
Howell, R ;
Schuster, D ;
Halkar, R ;
Davis, L .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :496S-496S
[48]   Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT and 131I radioiodine diagnostic scan in patients of differentiated thyroid carcinoma with skeletal metastases: evaluation of the role of 18F-FDG PET/CT in bony metastatic disease from differentiated thyroid cancer [J].
Parghane, R. V. ;
Basu, S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S392-S393
[49]   Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. [J].
Ito, S. ;
Kato, K. ;
Iwano, S. ;
Ishigaki, T. ;
Ikeda, M. ;
Tadokoro, M. ;
Makino, N. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 :S250-S250
[50]   Locoregional recurrence of differentiated thyroid cancer. [J].
ConteDevolx, B ;
DiCostanzo, V ;
Denizot, A ;
Niccoli, P ;
Henry, JF .
ANNALES D ENDOCRINOLOGIE, 1997, 58 (03) :240-241
12345